Top Feature

Sep 06, 2017
Pharmaceutical Executive
Cynthia Schwalm, EVP and president of North American commercial operations for Ipsen, talks to Pharm Exec about the importance of stepping outside of the C-suite and into the world of the patient.
Sep 05, 2017
Neil Grubert reviews the UK’s post-Brexit life sciences strategy, with a particular focus on the key area of market access.
Aug 29, 2017
Pharmaceutical Executive
IFPMA's new Assistant Director General speaks about her mission to use the organization’s international reach to find real and practical solutions to the most pressing global healthcare challenges.
Aug 28, 2017
Everyone’s talking value, but not everyone is willing to pin down the elusive concept. Pharm Exec talks with Steven Pearson, founder of the Institute for Clinical Effectiveness Review (ICER), about all things value-based.
Aug 21, 2017
Pharmaceutical Executive
Four strategic takeaways from this year's event that are important for pharma oncology leaders, by Maria Whitman and Sharon Karlsberg.
Aug 09, 2017
Pharmaceutical Executive
Pharm Exec’s 13th Annual Press Audit reveals a tonal undercurrent in sync with an industry unable to escape the glare of scrutiny.
Aug 05, 2017
Pharmaceutical Executive
For the life sciences industry in 2017, engaging across social media means less talking—and more listening. Peter Houston reports.
Jul 13, 2017
Pharmaceutical Executive
Digital interventions in drug adherence regimes are evolving to new levels of sophistication, but patient-behavior and privacy issues still present significant challenges.
Jul 12, 2017
Pharmaceutical Executive
The industry’s potential in tapping digital health to transform patient care hinges on new shifts in culture and business strategy. Michelle Maskaly reports.
Jul 07, 2017
Pharmaceutical Executive
Q&A with Merck KGaA’s Simon Sturge spotlights the development of one injection device that is helping change the treatment-adherence landscape.
native1_300x100
lorem ipsum